Similar articles

• Fatal glioblastoma multiforme in a patient with neurofibromatosis type I: the dilemma of systematic medical follow-up.

  Distelmaier F, Fahsold R, Reifenberger G, Messing-Juenger M, Schaper J, Schneider DT, Göbel U, Mayatepek E, Rosenbaum T. Distelmaier F, et al. Childs Nerv Syst. 2007 Mar;23(3):343-7. doi: 10.1007/s00381-006-0222-4. Epub 2006 Aug 29. Childs Nerv Syst. 2007. PMID: 17009007
• Clinicopathologic study of glioblastoma in children with neurofibromatosis type 1.

  Huttner AJ, Kieran MW, Yao X, Cruz L, Ladner J, Quayle K, Goumnerova LC, Irons MB, Ullrich NJ. Huttner AJ, et al. Pediatr Blood Cancer. 2010 Jul 1;54(7):890-6. doi: 10.1002/pbc.22462. Pediatr Blood Cancer. 2010. PMID: 20310005
• Glioblastoma in neurofibromatosis 1 patients without IDH1, BRAF V600E, and TERT promoter mutations.

  Shibahara I, Sonoda Y, Suzuki H, Mayama A, Kanamori M, Saito R, Suzuki Y, Mashiyama S, Uenohara H, Watanabe M, Kumabe T, Tominaga T. Shibahara I, et al. Brain Tumor Pathol. 2018 Jan;35(1):10-18. doi: 10.1007/s10014-017-0302-z. Epub 2017 Nov 14. Brain Tumor Pathol. 2018. PMID: 29138945
• Neurosurgical implications of neurofibromatosis Type I in children.

  Al-Otibi M, Rutka JT. Al-Otibi M, et al. Neurosurg Focus. 2006 Jan 15;20(1):E2. Neurosurg Focus. 2006. PMID: 16459992 Review.
• Glioblastoma in NF1: A Unique Entity-A Literature Review Focusing on Surgical Implication and Our Experience.

  Garbin E, Nicolè L, Magrini S, Ceccaroni Y, Denaro L, Basaldella L, Rossetto M. Garbin E, et al. Curr Oncol. 2025 Apr 21;32(4):242. doi: 10.3390/curroncol32040242. Curr Oncol. 2025. PMID: 40277798 Free PMC article. Review.